Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric rheumatology

Sunny San Diego to Welcome ACR Convergence 2023

Vanessa Caceres  |  May 1, 2023

An in-person poster hall and networking lounges are among the highlights attendees can expect at ACR Convergence 2023 in San Diego, Nov. 10–15.

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2023

A Medical Research Career Fueled by Curiosity

Gretchen Henkel  |  April 8, 2023

In January, Cecilia Pilar Chung, MD, MPH, began her new appointment as director of the Division of Rheumatology at the University of Miami. Previously, Dr. Chung was an associate professor of medicine at Vanderbilt University, Nashville, Tenn., for more than 10 years. At Vanderbilt, Dr. Chung built a strong research portfolio, focusing on the comparative…

Filed under:Professional TopicsProfiles Tagged with:Dr. Cecilia Chung

Diet May Help Reduce Inflammation in RA

Vanessa Caceres  |  March 27, 2023

In a small study, an anti-inflammatory diet helped reduce pain and swelling in a subset of people with rheumatoid arthritis (RA). Diet changes are complementary to standard treatment. Diet-related research can be challenging, but many patients with RA are motivated to try healthy changes.

Filed under:ConditionsRheumatoid Arthritis Tagged with:ACR on AirACR on Air podcastanti-inflammatory diet (ITIS)DietRheumatoid Arthritis (RA)

Contraception, Abortion & Rheumatic Disease after Dobbs

Samantha C. Shapiro, MD  |  December 12, 2022

PHILADELPHIA—As rheumatologists, we care for patients who may or may not want to become pregnant. We aren’t obstetricians or gynecologists, but several of the drugs we prescribe for active rheumatic disease can negatively affect pregnancy outcomes. It’s imperative we understand how to effectively counsel our patients with rheumatic disease on the risks and benefits of…

Filed under:ACR ConvergenceLegislation & AdvocacyMeeting ReportsProfessional Topics Tagged with:ACR Convergence 2022Dobbs v. Jackson Women's Health Organization

Bangalore House Call: A Patient’s Story

Charles Radis, DO  |  November 9, 2022

On a highway traversed by cement trucks and Beetle-Bug auto-rickshaws we travel north from Bangalore, India, for a house call. It is 2007, and the city leaves us grudgingly. Between fields of loose chocolate soil and sprigs of beans poking skyward, the skeletons of homes and businesses rise; armies of workers lay brick from wooden…

Filed under:ConditionsPatient PerspectiveRheumatoid Arthritis Tagged with:case reportHistory

Rheumatologists Can Guide Patients During Pregnancy, Family Planning

Vanessa Caceres  |  September 27, 2022

Rheumatologists should take an active role in patients’ reproductive health, including before, during and after pregnancy. Two experts offer insights into how rheumatologists can better care for their patients during these critical times.

Filed under:Conditions Tagged with:ACR on AirACR on Air podcastpregnancypregnant women

Telemedicine Provides New Challenges & Opportunities

Vanessa Caceres  |  September 21, 2022

The increased use of telemedicine that began in 2020 at the start of the COVID-19 pandemic will continue to provide new ways to expand patient care in rheumatology.

Filed under:Practice SupportTechnology

An Update from the RheumPAC Chair on the 117th Congress

Howard Blumstein, MD  |  September 3, 2022

RheumPAC has been working to ensure that individual legislators understand what rheumatology practices and patients face when it comes to delivering high quality care to those with rheumatic diseases and advocating for policies to support affordability of care, workforce expansion, prior authorization reform and fair reimbursement levels.

Filed under:Legislation & Advocacy Tagged with:ACR advocacyCongressional outreachLegislationRheumPAC

ACR Image Competition 2021 Results, Part 6

Yulia Vyzhga, MD, PhD  |  August 14, 2022

Featured Image from Europe & Central Asia Rheumatic Diseases of Childhood: Scleroderma These images depict a patient with a clinical presentation of juvenile dermatomyositis with typical skin manifestations of Gottron’s papules over the extensor surfaces of the joints, as well as hyperpigmentation. Yulia Vyzhga, MD, PhD, is a pediatric rheumatologist at National Pirogov Memorial Medical…

Filed under:ConditionsProfessional Topics Tagged with:biasdiagnostic imagingDiversityhealthcare disparitiesImage CompetitionRacism

Baricitinib Promising for Juvenile Idiopathic Arthritis

Michele B. Kaufman, PharmD, BCGP  |  July 19, 2022

In a study from Ramanan et al., baricitinib proved safe and effective for reducing the time to flare and frequency of flare in patients aged 2–18 years with juvenile idiopathic arthritis.

Filed under:ConditionsDrug UpdatesEULAR/OtherMeeting ReportsPediatric Conditions Tagged with:baricitinibEULARflareJIAjuvenile idiopathic arthritis (JIA)PediatricPediatric Rheumatology

  • « Previous Page
  • 1
  • …
  • 58
  • 59
  • 60
  • 61
  • 62
  • …
  • 95
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences